Will be a TO I reckon. Why would the pharma want to share the product with their peers? With their deep pocket, buying out noxopharm will be loose change.
Ann: Noxopharm IONIC Immuno-Oncology Trial Commences, page-6
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.06M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.0¢ | 10.8¢ | $21.52K | 195.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 168466 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 48475 | 2 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |